Medicinal Chemistry Strategies to Combat Neurodegenerative Diseases

References

1. WilsonD.M. CooksonM.R. Van Den BoschL. ZetterbergH. HoltzmanD.M. DewachterI. Hallmarks of Neurodegenerative Diseases.Cell2023186469371410.1016/j.cell.2022.12.032
   [Google Scholar]
2. CummingsJ. ZhouY. LeeG. ZhongK. FonsecaJ. ChengF. Alzheimer’s Disease Drug Development Pipeline: 2024.Alzheimers Dement.202410210.1002/trc2.12465
   [Google Scholar]
3. CavalliA. BolognesiM.L. MinariniA. RosiniM. TumiattiV. RecanatiniM. MelchiorreC. Multi-Target-Directed Ligands to Combat Neurodegenerative Diseases.J. Med. Chem.20085134737210.1021/jm7009364
   [Google Scholar]
4. BayraktarG. AlptüzünV. Recent Molecular Targets and Their Ligands for the Treatment of Alzheimer Disease.Curr. Top. Med. Chem.20242411810.2174/0115680266318722240809050235
   [Google Scholar]
5. LopesF.B. FernandesJ.P.S. UliassiE. Tackling Neuroinflammation in Cognitive Disorders with Single-Targeted and Multi-Targeted Histamine H3 Receptor Modulators.Curr. Top. Med. Chem.20242411010.2174/0115680266322294240816051818
   [Google Scholar]
6. KarS.S. GharaiS.R. SahuS.K. RavichandiranV. SwainS.P. The Current Landscape in the Development of Small-Molecule Modulators Targeting Sphingosine-1-Phosphate Receptors to Treat Neurodegenerative Diseases.Curr. Top. Med. Chem.20242411610.2174/0115680266288509240422112839
   [Google Scholar]